1. Home
  2. CRL vs LPX Comparison

CRL vs LPX Comparison

Compare CRL & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • LPX
  • Stock Information
  • Founded
  • CRL 1947
  • LPX 1973
  • Country
  • CRL United States
  • LPX United States
  • Employees
  • CRL N/A
  • LPX N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • LPX Forest Products
  • Sector
  • CRL Health Care
  • LPX Basic Materials
  • Exchange
  • CRL Nasdaq
  • LPX Nasdaq
  • Market Cap
  • CRL 7.1B
  • LPX 6.7B
  • IPO Year
  • CRL 2000
  • LPX N/A
  • Fundamental
  • Price
  • CRL $176.91
  • LPX $89.87
  • Analyst Decision
  • CRL Buy
  • LPX Buy
  • Analyst Count
  • CRL 14
  • LPX 8
  • Target Price
  • CRL $184.85
  • LPX $106.88
  • AVG Volume (30 Days)
  • CRL 807.2K
  • LPX 660.6K
  • Earning Date
  • CRL 08-06-2025
  • LPX 08-06-2025
  • Dividend Yield
  • CRL N/A
  • LPX 1.25%
  • EPS Growth
  • CRL N/A
  • LPX 56.47
  • EPS
  • CRL N/A
  • LPX 5.71
  • Revenue
  • CRL $4,022,597,000.00
  • LPX $2,941,000,000.00
  • Revenue This Year
  • CRL N/A
  • LPX N/A
  • Revenue Next Year
  • CRL $2.49
  • LPX $7.05
  • P/E Ratio
  • CRL N/A
  • LPX $15.69
  • Revenue Growth
  • CRL N/A
  • LPX 8.09
  • 52 Week Low
  • CRL $91.86
  • LPX $78.82
  • 52 Week High
  • CRL $254.15
  • LPX $122.87
  • Technical
  • Relative Strength Index (RSI)
  • CRL 71.29
  • LPX 51.33
  • Support Level
  • CRL $146.26
  • LPX $87.49
  • Resistance Level
  • CRL $184.17
  • LPX $90.20
  • Average True Range (ATR)
  • CRL 6.31
  • LPX 2.51
  • MACD
  • CRL 1.63
  • LPX -0.05
  • Stochastic Oscillator
  • CRL 80.84
  • LPX 33.70

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.

Share on Social Networks: